|
|
Volumn 10, Issue 4, 2004, Pages 329-330
|
|
Recognition of tumor vessel normalization as a new antiangiogenic concept (multiple letters)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CETUXIMAB;
DOXORUBICIN;
FUMAGILLOL CHLOROACETYLCARBAMATE;
IMATINIB;
PACLITAXEL;
RAZOXANE;
TRASTUZUMAB;
ANGIOGENESIS INHIBITOR;
ANGIOGENESIS;
ARTHRITIS;
CANCER;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CARDIOTOXICITY;
CLINICAL TRIAL;
CROHN DISEASE;
DIABETIC RETINOPATHY;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG POTENTIATION;
HUMAN;
KAPOSI SARCOMA;
LETTER;
PRIORITY JOURNAL;
PSORIASIS;
PSORIATIC ARTHRITIS;
TUMOR BLOOD FLOW;
TUMOR VASCULARIZATION;
NEOPLASM;
NEOVASCULARIZATION (PATHOLOGY);
NOTE;
VASCULARIZATION;
ANGIOGENESIS INHIBITORS;
HUMANS;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
|
|
EID: 1942486848
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm0404-329a Document Type: Letter |
|
Times cited : (17)
|
|
References (0)
|
